[go: up one dir, main page]

DK172036B1 - Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf - Google Patents

Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf Download PDF

Info

Publication number
DK172036B1
DK172036B1 DK174984A DK174984A DK172036B1 DK 172036 B1 DK172036 B1 DK 172036B1 DK 174984 A DK174984 A DK 174984A DK 174984 A DK174984 A DK 174984A DK 172036 B1 DK172036 B1 DK 172036B1
Authority
DK
Denmark
Prior art keywords
factor viii
coagulant
polypeptides
viii
human factor
Prior art date
Application number
DK174984A
Other languages
Danish (da)
English (en)
Other versions
DK174984A (da
DK174984D0 (da
Inventor
Theodore S Zimmerman
Carol A Fulcher
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK172036(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Publication of DK174984D0 publication Critical patent/DK174984D0/da
Publication of DK174984A publication Critical patent/DK174984A/da
Application granted granted Critical
Publication of DK172036B1 publication Critical patent/DK172036B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK174984A 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf DK172036B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US48110583 1983-03-31
US55650883A 1983-11-30 1983-11-30
US55650883 1983-11-30

Publications (3)

Publication Number Publication Date
DK174984D0 DK174984D0 (da) 1984-03-30
DK174984A DK174984A (da) 1984-10-01
DK172036B1 true DK172036B1 (da) 1997-09-22

Family

ID=27046849

Family Applications (2)

Application Number Title Priority Date Filing Date
DK174984A DK172036B1 (da) 1983-03-31 1984-03-30 Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf
DK050497A DK50497A (da) 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK050497A DK50497A (da) 1983-03-31 1997-05-02 Monoklonale antistoffer over for nye faktor VIII-koaguleringspolypeptider

Country Status (12)

Country Link
EP (3) EP0123945B2 (de)
JP (2) JPH0829089B2 (de)
AT (2) ATE155490T1 (de)
AU (1) AU572128B2 (de)
CA (1) CA1341506C (de)
DE (2) DE3486423T3 (de)
DK (2) DK172036B1 (de)
FI (1) FI841281L (de)
IE (2) IE80858B1 (de)
NO (1) NO167533C (de)
SG (2) SG48229A1 (de)
ZA (1) ZA842418B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
EP0152746B1 (de) * 1984-01-12 1991-08-14 Chiron Corporation Hybridom-Zellinien und monoklonale Antikörper gegen Faktor-VIII-C
EP0466199B1 (de) * 1984-01-12 2002-09-18 Chiron Corporation Für Faktor-VIIIc kodierende DNA-Sequenzen und verwandte DNA-Konstruktionen
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
IL74909A (en) * 1984-04-20 1992-01-15 Genentech Inc Preparation of functional human factor viii and dna sequences,expression vectors,transformed microorganisms and cell lines used therein
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
WO1988000210A1 (en) * 1986-06-24 1988-01-14 Nordisk Gentofte A/S A process for producing a coagulation active complex of factor viii fragments
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0690126B1 (de) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
WO1995003332A1 (en) * 1993-07-23 1995-02-02 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
PT1820516E (pt) 1999-02-22 2013-10-31 Baxter Int Novas formulações de factor viii isentas de albumina
EP1418810A4 (de) 2001-08-03 2006-08-02 Us Gov Health & Human Serv Orale behandlung von hämophilie
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
AU572128B2 (en) 1988-05-05
IE80638B1 (en) 1998-10-21
ATE135400T1 (de) 1996-03-15
JPH0829089B2 (ja) 1996-03-27
DK50497A (da) 1997-05-02
DE3486423T3 (de) 2001-02-08
FI841281A7 (fi) 1984-10-01
EP0770396A2 (de) 1997-05-02
EP0123945A1 (de) 1984-11-07
EP0561427B1 (de) 1997-07-16
DE3486453D1 (de) 1997-08-21
EP0123945B2 (de) 2000-04-19
EP0561427A1 (de) 1993-09-22
DE3486423D1 (de) 1996-04-18
JPH0638790A (ja) 1994-02-15
DE3486423T2 (de) 1996-09-19
EP0770396A3 (de) 1997-07-23
NO167533B (no) 1991-08-05
FI841281L (fi) 1984-10-01
ATE155490T1 (de) 1997-08-15
NO167533C (no) 1991-11-13
ZA842418B (en) 1984-11-28
IE80858B1 (en) 1999-04-21
DK174984A (da) 1984-10-01
SG48229A1 (en) 1998-04-17
NO841277L (no) 1984-10-01
DE3486453T2 (de) 1998-02-26
DK174984D0 (da) 1984-03-30
CA1341506C (en) 2006-06-06
IE960783L (en) 1984-09-30
SG49675A1 (en) 1998-06-15
EP0123945B1 (de) 1996-03-13
IE840788L (en) 1984-09-30
JPS59184130A (ja) 1984-10-19
FI841281A0 (fi) 1984-03-30
AU2627284A (en) 1984-10-04

Similar Documents

Publication Publication Date Title
DK172036B1 (da) Faktor VIII:C-koaguleringsmiddel, fremgangsmåde til fremstilling heraf samt fremgangsmåde til udvinding heraf
US4657894A (en) New factor VIII coagulant polypeptides
US4877614A (en) Biologically active fragments of human antihemophilic factor and method for preparation thereof
Clezardin et al. Complex formation of human thrombospondin with osteonectin
Kandiah et al. Beta2-glycoprotein I
Siddiqui et al. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
US4649132A (en) Treatment of Factor VIII inhibitors
US4886876A (en) Factor VIII coagulant polypeptides
Warn-Cramei et al. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor)
US5371073A (en) Polypeptide factors from colostrum
US4857635A (en) Factor VIII coagulant polypeptides and monoclonal antibodies tof them
JPH02296A (ja) ８因子のフォン・ビルブラント因子結合ドメイン
US5214033A (en) Factor VIII coagulant polypeptides
Kosaka et al. Hyperviscosity syndrome associated with an idiopathic monoclonal IgA-rheumatoid factor
Vingsbo et al. Association of pepsin with type II collagen (CII) breaks control of CII autoimmunity and triggers development of arthritis in rats
JP2006316062A (ja) 因子ｖｉｉｉの抗原ポリペプチド配列、その断片および／またはエピトープ
US5101016A (en) Factor VIII coagulant polypeptides and monoclonal antibodies to them
JPH058679B2 (de)
US5747337A (en) Factor VIII coagulant polypeptides and monoclonal antibodies to them
Leung et al. Isolation and characterization of monoclonal antibody directed against bovine αs2-casein
Boström et al. Evidence for a structural relationship between apoB75 kDa and human plasma apolipoprotein B100, from translation of human liver mRNA in vitro and immunochemical studies with monoclonal and polyclonal antibodies
JPH0753757B2 (ja) モノクローナル抗体及びその使用方法
JPH0794475B2 (ja) 純粋なエリスロポエチンの製造法
US5272255A (en) Polypeptide factors from colostrum
ASAI et al. A Study of Calcium-Binding Ig A (K) Glo-bulin Produced by Myeloma Cells

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired